期刊文献+

骨髓间充质干细胞移植治疗实验性肺动脉高压大鼠血流动力学指标的变化 被引量:5

Hemodynamic Parameter Changes in Pulmonary Arterial Hypertension Treated by Transplantation of Bone Marrow Mesenchymal Stem Cells in Experimental Rats
原文传递
导出
摘要 目的探讨骨髓间充质干细胞(MMSCs)移植治疗大鼠实验性肺动脉高压(PAH)后血流动力学指标的变化。方法取SD大鼠骨髓,经贴壁筛选法体外培养并纯化MMSCs,移植前采用Hoechst33342荧光染料标记。SD大鼠90只随机分为3组(n=30):MMSCs移植组(M组),单纯PAH组(H组)和正常对照组(N组)。M组采用野百合碱(50mg/kg)注射复制PAH模型成功后21d经舌下静脉移植5×109L-1的MMSCs细胞悬液1mL;H组复制PAH模型后21d移植1mL低糖伊格尔培养基(L-DMEM)细胞培养液;N组注射9g/L盐水(6mL/kg)。饲养28d,观察各组动物动脉血气指标、右室收缩压(RVSP)、右心指数及肺小动脉血管的变化。结果H组大鼠注射野百合碱21d后RVSP、右心指数、管壁中膜厚度(MT)显著增高,但管腔面积(VA)与血管总面积(TAA)比值(VA%)及动脉血pH值、pa(O2)、HCO3-均显著下降;M组移植MMSCs28d后与H组比较,RVSP显著降低[(32.20±2.32)mmHgvs(48.30±1.56)mmHgP<0.05],右心指数下降[(38.80±3.24)%vs(45.10±3.43)%P<0.05],M组血气分析结果显示pH值、pa(O2)、HCO3-值接近N组。荧光显微镜观察到M组荧光标记的MMSCs在肺内定植,且分化成大量的侧支循环,肺动脉重构得到有效逆转。结论MMSCs移植可有效减轻甚至逆转野百合碱诱导的大鼠PAH进程,明显改善其心功能及血流动力学指标。 Objective To explore hemodynamic parameter changes in pulmonary arterial hypertension(PAH) treated by transplantation of bone marrow mesenchymal stem cells(MMSCs) in the experimental rats. Methods MMSCs cells were collected from bone marrow of Spra- gue -Dawleye(SD) rat's femoral and tibial bones,cultured and passaged in vitro,then stained by Hoechst 33342 fluorescence dye stuff. Nine- ty healthy male SD rats were randomly divided into 3 groups ( n = 30 ) : normal control group ( group N ), MMSCs transplanted group ( group M) ,PAH model group (group H). The rats in the two latter groups were given a single subcutaneous erotaline(50 mg/kg) to establish the model of PAH. The rats of group N were injected respectively a single subcutaneous 9 g/L saline water (6 mL/kg). After 21 days,5 ×10^9 L-1 MMSCs cultured in 1 mL phosphate - buffered saline were infused into the rats respectively in group M by sublingual vein and 1 mL L - DMEM was given in group H; The indexalso of right ventricle systolic pressure(RVSP) ,right ventricle hypertrophy index ,arterial blood gas a- nalysis and the changes of small pulmonary blood vessel were observed after 28 days. Results The administration of MMSCs 28 days after PAH nearly completely prevented the increase in RVSP with PAH alone [ (32.20 ± 2.32) mmHg vs (48.30 ± 1.56) mmHg P 〈 0.05 ], right ventricle hypertrophy indexalso degraded[ (38.80 ±3.24)% vs (45.10±3.43) % P〈0.05] ,and relative media thickness raised obviously but the percentage of vessel area( VA% ) decreased, results of blood gas analysis such as pH ,pa(O2 ), HCO3 -degraded significant- ly. MMSCs labeled Hoechst 33342 were observed and were permanently planted and differentiated into plentiful collateral circulations in lung by fluorescence microscope. The pulmonary arteries remodeling was attenuated effectively in MMSCs group M. Conclusions These findings indicate that MMSCs might reduce and even reversion the progression of PAH induced by crotaline. And the heart function and hemodynamic parameter can be improved obviously.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2009年第1期14-17,共4页 Journal of Applied Clinical Pediatrics
基金 国家自然科学基金项目资助(30560159) 教育部新世纪优秀人才支持计划项目资助(NCET-05-0820) 贵州省高校自然科学基金资助(黔科教2005-7)
关键词 肺动脉高压 骨髓间充质干细胞 移植 血流动力学 大鼠 pulmonary arterial hypertension bone marrow mesenchymal stem cells transplantation hemodynamics rat
  • 相关文献

参考文献11

  • 1Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension[J]. J Clin Invest,2008,118(7) :2372 -2379.
  • 2Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction[ J.]. Nat Med,2006,12(4) :459 -465.
  • 3Benza RL, Park MH, Keogh A, etal. Management of pulmonary arterial hypertension with a focus on combination therapies [ J ]. J Heart Lung Transplant,2007,26(5 ) :437 -446.
  • 4Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self - renewal and differentiation[J]. Arthritis Res Ther,2007,9( 1 ) :204 -208.
  • 5Badillo AT, Redden RA, Zhang L, et al. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure [J]. Cell Tissue Res,2007 ,329 ( 2 ) :301 -311.
  • 6Zhao YD, Courtman DW, Deng Y, et al. Rescue of monocrotaline- induced pulmonary arterial hypertension using bone marrow- derived endothelial - like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease [ J ]. Circ Res, 2005,96 (4) :442 - 450.
  • 7Zeng C, Wang X, Hu X, et al. Autologous endothelial progenitor cells transplantation for the therapy of primary pulmonary hypertension [ J ]. Med Hypotheses,2007,68(6) :1292 - 1295.
  • 8Novotny NM, Markel TA, Crisostomo PR, et al. Differential IL- 6 and VEGF secretion in adult and neonatal mesenchymal stem cells:Role of NF-kB[ J]. Cytokine,2008,43 (2) :215 -219.
  • 9Kucic T,Copland IB,Cuerquis J,et al. Mesenchymal stromal cells genetically engineered to overexpress IGF - I enhance cell - based gene therapy of renal failure- induced anemia[ J]. Am J Physiol Renal Physiol, 2008,295 (2) :488 - 496.
  • 10Kim DH, Yoo KH, Choi KS, et al. Gene expression profile of cytokine and growth factor during differentiation of bone marrow - derived mesenehymal stem cell [ J ]. Cytokine, 2005,31 ( 2 ) : 119 - 126.

同被引文献59

  • 1张石革,马国辉,臧靖.回眸与展望——细胞集落刺激因子的临床评价[J].中国医院用药评价与分析,2005,5(3):142-145. 被引量:5
  • 2黄瑶,李立,汤永强.肝细胞生长因子对牛视网膜血管内皮细胞的促增生移行效应[J].眼科研究,2006,24(1):50-53. 被引量:5
  • 3熊忠讯,刘文英.内皮素在新生儿持续性肺动脉高压中的作用[J].中华小儿外科杂志,2006,27(9):488-491. 被引量:4
  • 4Rubin LJ. Pathology and pathophysiology of primary pulmonary hyper- tension. Am J Cardiol, 1995,75 : 51A-54A.
  • 5Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripoteney of mesen- ehymal stem cells derived from adult marrow. Nature, 2002,418 : 41 - 49.
  • 6Zhao YD, Courtman DW, Deng Y, et al. Rescue of monocrotaline-in- duced pulmonary arterial hypertension using bone marrow-derlved en- dothelial-like progenitor cells. Circ Res ,2005,96:442-450.
  • 7Chan SY, Loscalzo J. Pathogenic mechanisms of pulmonary arterial hy- pertension [ J ]. J Mol Cell Cardio1,2008,44 ( 1 ) : 14 - 30.
  • 8Zhang XL, Tang TF, Shi Q, et al. The immunologic properties of undif- ferentiated and osteogenic differentiated mouse mesenchymal stem cells and its potential application in bone regeneration[ J ]. Immunobi- ology ,2009,214 ( 3 ) : 179 - 186.
  • 9Miljkovic ND,Cooper GM, Mavra KG. Chondrogenesis, bone morpho- genetic protein - d and mesenchymal stem cells [ J ]. Osteoarthfitis Cartilage ,2008,16 ( 10 ) : 1121 - 1130.
  • 10Dharmasaroja P. Bone marrow - derived mesenchymal stem cells for the treatment of ischemic stroke [ J ]. J Clin Neurosci,2009,16 ( 1 ) : 12 -20.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部